Glucocorticoid Use in Patients Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations

References

• Zhang J, Zheng J, Huang K, Chen Y, Yang J, Yao W. Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study. Ther Adv Respir Dis. 2018;12:1753466618769514. doi:10.1177/1753466618769514
   Web of Science ®Google Scholar
• Woods JA, Wheeler JS, Finch CK, Pinner NA. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:421–430. doi:10.2147/COPD.S51012
   PubMed Web of Science ®Google Scholar
• Sivapalan P, Rutishauser J, Ulrik CS, et al. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials. Respir Res. 2021;22:155. doi:10.1186/s12931-021-01745-5
   PubMed Web of Science ®Google Scholar
• GOLD Executive Committee. Global initiative for chronic obstructive lung disease; 2019. Available from: www.goldcopd.org2019. Accessed February 05, 2023.
   Google Scholar
• GOLD Executive Committee. Global initiative for chronic obstructive lung disease; 2016. Available from: www.goldcopd.org2016. Accessed February 05, 2023.
   Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186(1):48–55. doi:10.1164/rccm.201108-1553OC
   PubMed Web of Science ®Google Scholar
• Serafino-Agrusa L, Scichilone N, Spatafora M, Battaglia S. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: a case-control study. Pulm Pharmacol Ther. 2016;37:89–94. doi:10.1016/j.pupt.2016.03.004
   PubMed Web of Science ®Google Scholar
• Cai B. Chinese expert consensus on the acute exacerbation of chronic obstructive pulmonary disease (draft). Chin J Respir Crit Care Med. 2013;12:541–550.
   Google Scholar
• Wu L, Lan N, Yang X. Effects of empirical glucocorticoid use on severe acute exacerbation of COPD during hospitalization. Int J Chron Obstruct Pulmon Dis. 2021;16:2419–2431. doi:10.2147/COPD.S300789
   PubMed Web of Science ®Google Scholar
• Vestbo J, Vogelmeier CF, Small M, Siddall J, Fogel R, Kostikas K. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. Int J Chron Obstruct Pulmon Dis. 2019;14:853–861. doi:10.2147/COPD.S189585
   PubMed Web of Science ®Google Scholar
• Wing K, Williamson E, Carpenter JR, et al. Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results. BMJ Open. 2018;8:e019475. doi:10.1136/bmjopen-2017-019475
   PubMed Web of Science ®Google Scholar
• Rhee CK. Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome. Korean J Intern Med. 2015;30:443–449. doi:10.3904/kjim.2015.30.4.443
   PubMed Web of Science ®Google Scholar
• Gao P, Zhang J, He X, Hao Y, Wang K, Gibson PG. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS One. 2013;8:e57678. doi:10.1371/journal.pone.0057678
   PubMed Web of Science ®Google Scholar
• David B, Bafadhel M, Koenderman L, De Soyza A. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait. Thorax. 2021;76:188–195. doi:10.1136/thoraxjnl-2020-215167
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184:662–671. doi:10.1164/rccm.201104-0597OC
   PubMed Web of Science ®Google Scholar
• Falk JA, Minai OA, Mosenifar Z. Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:506–512. doi:10.1513/pats.200707-096ET
   PubMedGoogle Scholar
• Hasegawa K, Camargo CA. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD. Respirology. 2016;21:761–764. doi:10.1111/resp.12724
   PubMed Web of Science ®Google Scholar
• Llanos JP, Ortega H, Germain G, et al. Health characteristics of patients with asthma, COPD and asthma-COPD overlap in the NHANES database. Int J Chron Obstruct Pulmon Dis. 2018;13:2859–2868. doi:10.2147/COPD.S167379
   PubMed Web of Science ®Google Scholar
• Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005;60:193–198. doi:10.1136/thx.2004.032516
   PubMed Web of Science ®Google Scholar
• Scholl T, Kiser TH, Vondracek SF. Evaluation of systemic corticosteroids in patients with an acute exacerbation of COPD and a diagnosis of pneumonia. Chronic Obstr Pulm Dis. 2018;5:57–65. doi:10.15326/jcopdf.5.1.2017.0157
   PubMed Web of Science ®Google Scholar
• Yu S, Fang Q, Li Y. Independent factors associated with pneumonia among hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease. Medicine (Baltimore). 2018;97:e12844. doi:10.1097/MD.0000000000012844
   PubMed Web of Science ®Google Scholar
• Liu DS, Han XD, Liu XD. Current Status of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Chin Med J (Engl). 2018;131:1086–1091. doi:10.4103/0366-6999.230727
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Barbeta E, Ielpo A, Torres A. Management of severe acute exacerbations of COPD: an updated narrative review. Multidiscip Respir Med. 2018;13:36. doi:10.1186/s40248-018-0149-0
   PubMed Web of Science ®Google Scholar